SYMVESS
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98050185
- Registration number
- 8033398
- Mark type
- Stylized text
- Filed
- 20 Jun 2023
- Published for opposition
- 16 Jul 2024
- Registered
- 18 Nov 2025
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Bioengineered connective tissue intended for subsequent implantation; biological implants comprising tissue; biological tissue grafts; vascular grafts; bioengineered blood vessels comprising tissue intended for subsequent implantation; biological tissue implants comprising tissue for use in surgery and regenerative medicine; human tissue substitute comprising tissue material derived from biological tissue intended for subsequent implantation
Owner
- Humacyte Global, Inc., Durham, NC, US
- Humacyte Global, Inc., Durham, NC, US
- Humacyte Global, Inc., Durham, NC, US
Prosecution history
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2025 — USE AMENDMENT FILED
- 12 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 May 2025 — SOU EXTENSION 2 GRANTED
- 12 May 2025 — SOU EXTENSION 2 FILED
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2025 — SOU EXTENSION 1 GRANTED
- 25 Feb 2025 — SOU EXTENSION 1 FILED